GeneTex
United States (US)

FGF2 antibody [FB-8]

Cat No. GTX10419

Host Mouse
Clonality Monoclonal
Clone Name FB-8
Isotype IgG1
Application WB, Dot, ELISA, Neut, RIA
Reactivity Human, Bovine
APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Dilution
WB Assay dependent
Dot Assay dependent
ELISA Assay dependent
Neut 5 μg/ml
RIA Assay dependent
Not tested in other applications.

Calculated MW

31 kDa. ( Note )

Positive Control

recombinant human FGF2
PROPERTIES

Form

Liquid

Buffer

PBS pH7.4

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Antigen Species

Human

Immunogen

recombinant human FGF2.

Purification

Purified immunoglobulin

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Fibroblast Growth Factor 2,Bfgf,Fgf-2,Fgfb,Hbgf-2,Fgf2

Background

Fibroblast growth factors (FGFs) are members of a family of polypeptides that are potent regulators of cell proliferation, differentiation and function. The FGF family consists of seven members with 30-50% sequence identity at the amino acid level and with conservation of the positions of two cysteine residues. The factors are designated FGF-1 through FGF-7; the names FGF acidic and basic are used for FGF-1 and FGF-2, respectively. Acidic and basic fibroblast growth factor (aFGF and bFGF, respectively) are members of a small family of heparin binding growth factors (HBGF). Comparisons of the primary structure have shown that aFGF and bFGF are closely related mitogens with 55% homology. When isolated from natural sources, bFGF usually has an apparent mass of about 18 kDa, but a variety of larger forms, up to 24 kDa, can exist. Natural bFGF exists in three forms, the 154 amino-acid form and two truncated versions of 146 and 131 amino acids lacking the N-terminal 9 and 24 residues, respectively. Depending on the organ from which it is purified, either the complete or truncated forms of bFGF may be present. In pituitary and brain the complete form predominates, in kidney and corpus luteum only the truncated form can be detected, and in adrenal glands, both forms coexist. Human and bovine bFGF are nearly identical in sequence, differing at only two positions. The largest (154 aa) form of both human and bovine aFGF share all but 12 amino acids. FGFs play crucial roles in normal development, in the maintenance of tissues, and in wound healing and repair. They have been implicated in a wide range of pathological conditions, including tumorigenesis and metastasis. Both aFGF and bFGF exert their mitogenic influence via saturable high-affinity receptors on a variety of cells of mesodermal and neuroectodermal origin, including endothelial cells, smooth muscle cells, fibroblasts, gliomas, chondrocytes, hepatocytes, epithelial cells, and myoblasts. As expected from the sequence homology between the acidic and basic forms of FGF and from their ability to support the proliferation in vitro of the same spectrum of target cells, both aFGF and bFGF interact with the same cell surface receptor.

Database

Research Area